期刊文献+

目标miRNAs在口腔白斑癌变患者唾液中的表达研究 被引量:1

Expression of mi RNAs in patients' saliva with oral leukoplakia
原文传递
导出
摘要 目的:寻找能够准确评估口腔白斑癌变风险的生物标志物指导临床工作。方法:随机收集未经治疗的口腔癌患者、稳定白斑、癌变白斑患者各20例,收集唾液标本,采用RT-q PCR探讨癌变口腔白斑患者唾液mi RNA的变化。结果:癌变白斑患者唾液中mi R-339-5p、mi R-144、mi R--521-3p、mi R-429和mi R-181a与病变组织中的表达情况一致(P<0.10)。结论:mi RNA表达改变的唾液检测有望成为一种理想的、无创的早期检测癌变口腔白斑的新方法。 Objective:Clinical and histological assessments are not reliable in predicting which precursor lesions will progress.The aim of this study was to assess the potential of a noninvasive approach to assess progress risk of oral precancerous lesions.Method:We used RT-q PCR to detect mi RNA targets from the microarray results in saliva samples of these patients.Result:We identified a specific mi RNA signature that is aberrantly expressed in progressing oral LGD leukoplakias.Similar expression patterns were detected in saliva samples from these patients.Conclusion:These results show promise for using saliva mi RNA signature for monitoring of cancer precursor lesions and early detection of disease progression.
出处 《临床口腔医学杂志》 2015年第7期407-409,共3页 Journal of Clinical Stomatology
关键词 口腔白斑 癌变 MI RNAS 唾液标志物 Oral leukoplakia Malignant transformation mi RNAs Salivary biomarker
  • 相关文献

参考文献14

  • 1Napier SS,Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature[J]. J Oral Pathol Med, 2008,37 (1) : 1-10.
  • 2Bouquot JE, Weiland LH, Kirland LT. Leukoplakia and carcinoma in situ associated with invasive oral/oropharyngeal carcinoma in Rochester, Minn., 1935-1984 1. Oral Surg Oral Med Oral Pathol, 1988, 65 (2) : 199-207.
  • 3Park NJ, Zhou H, Elashoff D, et al. Salivary microRNA: discovery, characterization, and clinical utility fororal cancer detection Eli. Clin Cancer Res, 2009, 15 (17) : 5473-5477.
  • 4Etheridge A, Lee I, Hood L, et al. Extracellular microRNA: A new source of biomarkers [J]. Mutat Res 2011,717 (1-2) : 85-90.
  • 5von Brandenstein M, Pandarakalam JJ, Kroon L, et al. Fries JW: Mi- eroRNA 15a, inversely correlated to PKCct, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples[J]. Am J Pathol 2012, 80(5) : 11787-1797.
  • 6Spielmann N, Wong DT. Saliva. diagnostics and therapeutic perspec- tives [J]. Oral Dis, 2011,17 (4) : 345-354.
  • 7Wang B, Hsu SH, Majumder S, et al. TGFbeta-mediated upregnlation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3 [J]. Oncogene, 2010, 29 (12) : 1787-1797.
  • 8Frequent deletions and down-regnlation of miero-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia[J]. Proc Natl Acad Sci, 2002, 99 (24) : 15524- 15529.
  • 9Lu J, Getz G, Miska EA, et al. MieroRNA expression profiles classify human cancers [J]. Nature 2005,435 (7043) : 834-838.
  • 10O'Dnnnell ICtt, Wentzel EA,Zeller KI,et al. c-Myc-regulated mi- croRNAs modulate E2F1 expression [J]. Nature 2005,435 (7043): 839-843.

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部